No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Breast Neoplasms* / mortality
-
Breast Neoplasms* / therapy
-
Disease-Free Survival
-
Female
-
Humans
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / mortality
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / therapy
-
Neoplasms, Second Primary* / mortality
-
Neoplasms, Second Primary* / therapy
-
Risk Factors
-
Survival Rate